Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes

Abstract Background Colorectal cancer (CRC) presents significant treatment challenges due to its high heterogeneity and complex intercellular interactions. Further exploration of CRC subtypes and interactions among tumor-specific clusters will facilitate the development of personalized treatment str...

Full description

Saved in:
Bibliographic Details
Main Authors: Youpeng Wang, Xingfeng Qiu, Qinghai Li, Jiale Qin, Lvlan Ye, Xiang Zhang, Xingxiang Huang, Xiangqiong Wen, Ziyang Wang, Weiling He, Yuqin Di, Qi Zhou
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06103-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025004753747968
author Youpeng Wang
Xingfeng Qiu
Qinghai Li
Jiale Qin
Lvlan Ye
Xiang Zhang
Xingxiang Huang
Xiangqiong Wen
Ziyang Wang
Weiling He
Yuqin Di
Qi Zhou
author_facet Youpeng Wang
Xingfeng Qiu
Qinghai Li
Jiale Qin
Lvlan Ye
Xiang Zhang
Xingxiang Huang
Xiangqiong Wen
Ziyang Wang
Weiling He
Yuqin Di
Qi Zhou
author_sort Youpeng Wang
collection DOAJ
description Abstract Background Colorectal cancer (CRC) presents significant treatment challenges due to its high heterogeneity and complex intercellular interactions. Further exploration of CRC subtypes and interactions among tumor-specific clusters will facilitate the development of personalized treatment strategies. Methods Single-cell RNA sequencing and bulk RNA sequencing datasets were integrated to determine CRC metabolic subtypes by hierarchical clustering. The analysis was further extended to cellchat, pseudotime, immune infiltration, and clinicopathological relevance to explore the characteristics of secreted frizzled related protein 2 (SFRP2) + cancer-associated fibroblast (CAF) clusters, and validated by spatial transcriptomics (ST), in vivo experiments, and multiple immunohistochemistry (mIHC). Results CRC samples were stably classified into three heterogeneous metabolic subtypes, each exhibiting different microenvironment and CAF heterogeneity, particularly in the distribution of SFRP2 + CAF, which was aligned with metabolic activity. SFRP2 + CAF exhibits high extracellular matrix (ECM) activity and is closely involved in cellular communication, not only promoting the malignant progression of cancer cells but also inducing the differentiation of Tregs. Compared to responders of chemotherapy, the proportion of SFRP2 + CAFs is significantly increased in non-responders. Importantly, mIHC and ST analyses confirm that cancer cells with low expression of agmatinase (AGMAT) can recruit SFRP2 + CAFs, and Treg infiltration surrounding SFRP2 + CAFs was observed. AGMAT combined with oxaliplatin showed the best efficacy in vivo, which may be associated with the inhibition of SFRP2 + CAF infiltration. Conclusions Our study identified and described the potential protumor biological properties of SFRP2 + CAFs, and AGMAT may be a valuable target for disrupting their properties.
format Article
id doaj-art-e9f72ffe8bca421eb9020e0c2add3a10
institution DOAJ
issn 1479-5876
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-e9f72ffe8bca421eb9020e0c2add3a102025-08-20T03:00:58ZengBMCJournal of Translational Medicine1479-58762025-02-0123111810.1186/s12967-025-06103-3Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypesYoupeng Wang0Xingfeng Qiu1Qinghai Li2Jiale Qin3Lvlan Ye4Xiang Zhang5Xingxiang Huang6Xiangqiong Wen7Ziyang Wang8Weiling He9Yuqin Di10Qi Zhou11Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Gastrointestinal Surgery, School of Medicine, Xiang’an Hospital of Xiamen University, Xiamen UniversityDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen UniversityDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Gastrointestinal Surgery, School of Medicine, Xiang’an Hospital of Xiamen University, Xiamen UniversityDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityCenter of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityAbstract Background Colorectal cancer (CRC) presents significant treatment challenges due to its high heterogeneity and complex intercellular interactions. Further exploration of CRC subtypes and interactions among tumor-specific clusters will facilitate the development of personalized treatment strategies. Methods Single-cell RNA sequencing and bulk RNA sequencing datasets were integrated to determine CRC metabolic subtypes by hierarchical clustering. The analysis was further extended to cellchat, pseudotime, immune infiltration, and clinicopathological relevance to explore the characteristics of secreted frizzled related protein 2 (SFRP2) + cancer-associated fibroblast (CAF) clusters, and validated by spatial transcriptomics (ST), in vivo experiments, and multiple immunohistochemistry (mIHC). Results CRC samples were stably classified into three heterogeneous metabolic subtypes, each exhibiting different microenvironment and CAF heterogeneity, particularly in the distribution of SFRP2 + CAF, which was aligned with metabolic activity. SFRP2 + CAF exhibits high extracellular matrix (ECM) activity and is closely involved in cellular communication, not only promoting the malignant progression of cancer cells but also inducing the differentiation of Tregs. Compared to responders of chemotherapy, the proportion of SFRP2 + CAFs is significantly increased in non-responders. Importantly, mIHC and ST analyses confirm that cancer cells with low expression of agmatinase (AGMAT) can recruit SFRP2 + CAFs, and Treg infiltration surrounding SFRP2 + CAFs was observed. AGMAT combined with oxaliplatin showed the best efficacy in vivo, which may be associated with the inhibition of SFRP2 + CAF infiltration. Conclusions Our study identified and described the potential protumor biological properties of SFRP2 + CAFs, and AGMAT may be a valuable target for disrupting their properties.https://doi.org/10.1186/s12967-025-06103-3Colorectal cancerSingle-cell RNA sequencingCancer-associated fibroblast (CAF)Chemoresistance
spellingShingle Youpeng Wang
Xingfeng Qiu
Qinghai Li
Jiale Qin
Lvlan Ye
Xiang Zhang
Xingxiang Huang
Xiangqiong Wen
Ziyang Wang
Weiling He
Yuqin Di
Qi Zhou
Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes
Journal of Translational Medicine
Colorectal cancer
Single-cell RNA sequencing
Cancer-associated fibroblast (CAF)
Chemoresistance
title Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes
title_full Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes
title_fullStr Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes
title_full_unstemmed Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes
title_short Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes
title_sort single cell and spatial resolved profiling reveals cancer associated fibroblast heterogeneity in colorectal cancer metabolic subtypes
topic Colorectal cancer
Single-cell RNA sequencing
Cancer-associated fibroblast (CAF)
Chemoresistance
url https://doi.org/10.1186/s12967-025-06103-3
work_keys_str_mv AT youpengwang singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT xingfengqiu singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT qinghaili singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT jialeqin singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT lvlanye singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT xiangzhang singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT xingxianghuang singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT xiangqiongwen singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT ziyangwang singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT weilinghe singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT yuqindi singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes
AT qizhou singlecellandspatialresolvedprofilingrevealscancerassociatedfibroblastheterogeneityincolorectalcancermetabolicsubtypes